NCT06835946 Impact of Anesthesia, Positive Pressure Ventilation and Modality of Imaging on the Echocardiographic Assessment of the Severity of Aortic Regurgitation
| NCT ID | NCT06835946 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Liege |
| Condition | Aortic Regurgitation Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess the impact of imaging modality (trans-thoracic echo (TTE) vs trans-esophageal echo (TEE)), anesthesia and positive pressure ventilation on the grading of aortic insufficiency. Patients scheduled for cardiac surgery and in whom a TEE is going to be performed intra-operatively will be enrolled. The grading of the aortic insufficiency will be compared between a TTE performed immediately before the induction of general anesthesia end the TEE performed after induction of general anesthesia.
Eligibility Criteria
Inclusion Criteria: * Known aortic regurgitation of any grade * Scheduled for a cardiac surgery procedure during which a trans-esophageal echo is planned. Exclusion Criteria: * Non sinus rhythm * Mitral regurgitation more than mild. * Pre-operative critical state (according to the definition of the EuroSCORE II) * Presence of a prosthetic aortic valve * Contra-indication to trans-esophageal echo
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06835946 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Regurgitation Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06835946 currently recruiting?
Yes, NCT06835946 is actively recruiting participants. Contact the research team at ahouben@chuliege.be for enrollment information.
Where is the NCT06835946 trial being conducted?
This trial is being conducted at Liège, Belgium.
Who is sponsoring the NCT06835946 clinical trial?
NCT06835946 is sponsored by University of Liege. The trial plans to enroll 100 participants.